GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy

Adjuvant oxaliplatin-based chemotherapy is widely used for stage III colorectal cancer (CRC) after curative surgery. CRC is a molecularly heterogeneous disease, and our current knowledge of therapeutic response-related genetic factors remains limited. N-acetylgalactosaminyltransferase 14 (GALNT14)-r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Lin, Wey-Ran, Chiang, Jy-Ming, Liang, Kung-Hao, Lim, Siew-Na, Lai, Ming-Wei, Tsou, Yung-Kuan, Hsieh, Tzu-Yun, Hsu, Chih-Kai, Yeh, Chau-Ting
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2016
Gaiak:
3500
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998711/
https://ncbi.nlm.nih.gov/pubmed/27124048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003487
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak